NSFDX | RCCTX | NSFDX / RCCTX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 8 years | 18 years | - |
Gain YTD | 9.400 | 9.013 | 104% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 250 | 400,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.16M | 15.7B | 0% |
Annual Yield % from dividends | 2.25 | 2.27 | 99% |
Returns for 1 year | 15.12 | 13.61 | 111% |
Returns for 3 years | -1.70 | -0.79 | 216% |
Returns for 5 years | -3.57 | 14.19 | -25% |
Returns for 10 years | N/A | 27.10 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FOSBX | 34.32 | 0.55 | +1.63% |
Tributary Small Company Instl Plus | |||
ARSYX | 15.05 | 0.05 | +0.33% |
AB Global Real Estate Investment Advisor | |||
PRHSX | 94.05 | 0.29 | +0.31% |
T. Rowe Price Health Sciences | |||
SEECX | 37.32 | N/A | N/A |
Steward Values Enhanced Lg Cap Index I | |||
ALARX | 49.05 | N/A | N/A |
Alger Capital Appreciation Instl I |